CD8A and cancer: Besides, the results mentioned above were validated via cancer cell lines and cancer cohorts, together manifesting the underlying mechanics of CD8A in reflecting the T-cell-inflamed profiles, and its potential as a biomarker in cancer diagnosis, prognosis, and therapeutic responses.